Log in
Forgot password ?
Become a member for free
Sign up
Sign up
Dynamic quotes 

4-Traders Homepage  >  Equities  >  Nyse  >  Pfizer Inc       

News SummaryMost relevantAll newsSector news 

Pfizer Inc. : Pfizer Will Remove Claims on Breast and Colon Health From Centrum Label -Reuters

share with twitter share with LinkedIn share with facebook
share via e-mail
07/05/2012 | 05:26pm EDT

Pfizer Inc. (>> Pfizer Inc.) said it will remove claims that its Centrum multivitamin supplements promote breast and colon health from labels over the next six months, following a complaint by a watchdog group, Reuters reported Thursday.

The company will also revise websites and advertising for Centrum, the report said.

The report said the Center for Science in the Public Interest sent a letter to Pfizer Chief Executive Ian Read in April outlining its complaints and threatening a lawsuit if the claims weren't removed.

In a statement, Pfizer said it "disagrees with CSPI's concerns, but has agreed to make these changes in order to fully resolve the issues raised by the organization," Reuters reported.

Full story at http://www.reuters.com/article/2012/07/05/pfizer-centrum-idUSL2E8I5BR820120705

Write to nymonitoring@dowjones.com

Stocks mentioned in the article : Pfizer Inc.
share with twitter share with LinkedIn share with facebook
share via e-mail
Latest news on PFIZER INC
07:02a PFIZER : XALKORI® (Crizotinib) Receives Approval In European Union For The Treat..
08/30 PFIZER : Seven Hampton schools get 'mini-makeovers' this summer
08/30 $200m Halliburton cash 'blown on presidential helicopter'
08/30 U.S. slams EU, but Apple tax demand first issued in Washington
08/30DJFDA Approves Novartis's Biosimilar to Amgen's Enbrel
08/29 PFIZER : St. Louis area manufacturer of EpiPens to produce Mylan's new generic v..
08/29DJMondelez Walks Away After Hershey Spurns Raised Bid
08/28 PFIZER : Cypress Creek Bridge could see repairs, partial shutdown in 2020
08/28 A $510,000 tab to clean Chase Bag site
08/28 PFIZER : IW Chamber offering free consultations for small business owners
More news
Sector news : Pharmaceuticals - NEC
11:32aDJSHIRE : Files 8K - Other Events
07:45aDJASTRAZENECA : Agrees to Pay $5.5 Million to Settle Alleged Bribery Probe
07:35aDJASTRAZENECA : Agrees to Pay $5.5 Million to Settle Alleged Bribery Probe
08/30DJWALGREENS BOOTS ALLIANCE : Theranos Walks Away From Zika Test
08/30 ASTRAZENECA : to pay $5.52 million to resolve U.S. SEC foreign bribery case
More sector news : Pharmaceuticals - NEC
News from SeekingAlpha
2015 Tracking Prem Watsa's Fairfax Financial Holdings Portfolio - Q2 2015 Update
2015 Antibiotics Stocks To Benefit From 21st Century Cures Act
2015 ISIS PHARMA STOCK DROPS ON GOOD NEWS : Re-Evaluating The Bull Case
2015 DOW DOGS : 14.63% More Returns From 5 Lowest Priced As Of August 6 Per indexArb
2015 Pfizer's GL-2045 an Orphan Drug for CIDP
Financials ($)
Sales 2016 52 846 M
EBIT 2016 19 400 M
Net income 2016 11 351 M
Debt 2016 19 710 M
Yield 2016 3,41%
P/E ratio 2016 19,12
P/E ratio 2017 15,80
EV / Sales 2016 4,38x
EV / Sales 2017 4,12x
Capitalization 211 570 M
More Financials
Duration : Period :
Pfizer Inc Technical Analysis Chart | 4-Traders
Full-screen chart
Income Statement Evolution
More Financials
Mean consensus OUTPERFORM
Number of Analysts 21
Average target price 39,5 $
Spread / Average Target 13%
Consensus details
EPS Revisions
More Estimates Revisions
Ian C. Read Chairman & Chief Executive Officer
Frank A. D'Amelio Chief Financial Officer & EVP-Business Operations
Freda C. Lewis-Hall Chief Medical Officer & Executive Vice President
Mikael Dolsten President-Worldwide Research & Development
W. Don Cornwell Independent Director
More about the company
Sector and Competitors
1st jan.Capitalization (M$)
PFIZER INC13.96%211 570
JOHNSON & JOHNSON16.31%326 855
ROCHE HOLDING LTD.-12.84%214 220
PFIZER INC.8.05%211 570
NOVARTIS AG-10.83%209 772
More Results